Order Article Reprints

Silva MdO, Castro-Amarante MF, Venceslau-Carvalho AA, Almeida BdS, Daher IP, Souza-Silva GAd, Yamamoto MM, Koike G, de Souza EE, Wrenger C, et al. Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein. Vaccines. 2024; 12(4):356. https://doi.org/10.3390/vaccines12040356

Silva, Mariângela de Oliveira, Maria Fernanda Castro-Amarante, Alexia Adrianne Venceslau-Carvalho, Bianca da Silva Almeida, Isabela Pazotti Daher, Guilherme Antonio de Souza-Silva, Marcio Massao Yamamoto, Gabriela Koike, Edmarcia Elisa de Souza, Carsten Wrenger, and et al. 2024. "Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein" Vaccines 12, no. 4: 356. https://doi.org/10.3390/vaccines12040356

Silva, M. d. O., Castro-Amarante, M. F., Venceslau-Carvalho, A. A., Almeida, B. d. S., Daher, I. P., Souza-Silva, G. A. d., Yamamoto, M. M., Koike, G., de Souza, E. E., Wrenger, C., Ferreira, L. C. d. S., & Boscardin, S. B. (2024). Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein. Vaccines, 12(4), 356. https://doi.org/10.3390/vaccines12040356